# Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA

> **NCT02109770** · — · COMPLETED · sponsor: **Natera, Inc.** · enrollment: 216 (actual)

## Conditions studied

- Microdeletion Syndromes
- Trisomy 21
- Trisomy 18
- Trisomy 13
- Sex Chromosome Abnormalities

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02109770
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2019-06
- **Final completion:** 2019-08
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2019-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02109770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02109770, "Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02109770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*